SCHEMBL30906338

CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O

nearest known ligand 0.61

Predicted protein targets (top 10)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	11/20	0.61

▸	ECE1	P42892	1/20	0.61

▸	MUS81	Q96NY9	1/20	0.61

▸	RXFP1	Q9HBX9	4/20	0.60

▸	GCGR	P47871	1/20	0.59

▸	GIPR	P48546	1/20	0.59

▸	VIPR1	P32241	1/20	0.59

▸	PTH1R	Q03431	3/20	0.58

▸	CCKBR	P32239	1/20	0.58

▸	VIPR2	P41587	1/20	0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30906515	0.98	GLP1R (0.64)	GLP1RECE1MUS81RXFP1GCGR
SCHEMBL30906526	0.97	GLP1R (0.66)	GLP1RECE1MUS81RXFP1GCGR
SCHEMBL30906386	0.97	GLP1R (0.61)	GLP1RECE1MUS81RXFP1GCGR
SCHEMBL31000905	0.91	GLP1R (0.66)	GLP1RECE1MUS81RXFP1PTH1R
SCHEMBL30092983	0.91	NPBWR1 (0.58)	GLP1RECE1MUS81RXFP1PTH1R
SCHEMBL30906498	0.91	GLP1R (0.69)	GLP1RECE1MUS81RXFP1PTH1R
SCHEMBL30906400	0.91	GLP1R (0.69)	GLP1RECE1MUS81GCGRGIPR
SCHEMBL30261961	0.91	PTH1R (0.67)	GLP1RECE1MUS81RXFP1GCGR
SCHEMBL30092988	0.91	RXFP1 (0.55)	GLP1RECE1MUS81RXFP1PTH1R
SCHEMBL29638070	0.90	GLP1R (0.65)	GLP1RECE1MUS81RXFP1GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4598964-A2	ANTI-IGE ANTIBODIES	Abwiz Bio, Inc. (US)	2025-08-13	—	—	EP	disclosed
US-20240182599-A1	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC.	2024-06-06	—	—	US	disclosed
WO-2024076785-A2	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC. (US)	2024-04-11	—	—	WO	disclosed